Saxenda Copay Card in 2026: Eligibility Rules, Maximum Savings, and What Happens When You Don't Qualify

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• The Saxenda Savings Card reduces eligible commercial-insurance copays to as low as $25 per month, with a maximum benefit of $200 per fill for up to 12 months
• Government-funded insurance (Medicare, Medicaid, TRICARE, VA) automatically disqualifies you from the manufacturer copay program under federal anti-kickback rules
• Patients whose insurance doesn't cover Saxenda at all cannot use the savings card, it only reduces existing copays, not replace coverage entirely
• The card expires after 12 consecutive fills or 365 days from first use, whichever comes first, and cannot be renewed under current Novo Nordisk policy

Direct answer (40-60 words)

The Saxenda Savings Card is Novo Nordisk's manufacturer copay assistance program for patients with commercial insurance. Eligible patients pay as little as $25 per month, with up to $200 in savings per fill for 12 months. Medicare, Medicaid, TRICARE, VA, and uninsured patients don't qualify. The card requires active Saxenda coverage through a non-government insurance plan.

Table of contents

1. How the Saxenda Savings Card actually works
2. The five eligibility requirements (and why each exists)
3. Maximum benefit breakdown by insurance tier
4. Who's automatically excluded (and the federal law behind it)
5. Real copay scenarios with and without the card
6. How to activate and use the card at the pharmacy
7. What happens when your 12-month limit expires
8. The Novo Nordisk Patient Assistance Program for low-income patients
9. Compounded liraglutide as the post-card alternative
10. What most articles get wrong about savings card stacking
11. The decision tree: card vs PAP vs compounded
12. FAQ

How the Saxenda Savings Card actually works

The Saxenda Savings Card is not a discount card. It's a manufacturer copay offset program that applies only after your insurance processes the claim.

Here's the transaction sequence at the pharmacy counter:

1. The pharmacist submits your prescription through your insurance card.
2. Your insurance applies its formulary tier rules, deductible status, and any prior authorization requirements.
3. The insurance returns an approved copay amount (for example, $275).
4. The pharmacist then applies the Saxenda Savings Card as a secondary payment source.
5. The card pays up to $200 of your copay, reducing your out-of-pocket cost to $75 in this example.

The card cannot:

• Replace insurance coverage if your plan doesn't cover Saxenda
• Apply to the full retail price if you're paying cash without insurance
• Combine with GoodRx, SingleCare, or other discount coupon programs
• Count toward your insurance deductible (the manufacturer pays the offset, not you)

This structure exists because of federal regulations. Manufacturer copay cards are legal for commercial insurance but prohibited for government-funded plans under the Anti-Kickback Statute (42 U.S.C. § 1320a-7b). The card is designed to keep patients on brand-name Saxenda instead of switching to cheaper alternatives, which is permissible in the commercial market but considered an illegal inducement in government healthcare programs.

The five eligibility requirements (and why each exists)

Requirement 1: You must have commercial insurance that covers Saxenda.

"Commercial insurance" means employer-sponsored plans, marketplace ACA plans, or private individual plans. The insurance must list Saxenda on its formulary, even if it's on a high tier or requires prior authorization.

If your plan explicitly excludes weight-loss medications or if Saxenda isn't on the formulary at all, the card doesn't apply. The card reduces a copay. If there's no copay because there's no coverage, there's nothing to reduce.

Requirement 2: You cannot be enrolled in any government-funded healthcare program.

This includes Medicare Part D, Medicaid, TRICARE, VA benefits, Indian Health Service, or any state pharmaceutical assistance program. Even if you're dual-eligible (Medicare + private supplemental insurance), the Medicare enrollment disqualifies you.

Why: The Anti-Kickback Statute prohibits manufacturers from offering anything of value to federal healthcare beneficiaries that could influence prescribing decisions. A $200-per-month copay offset qualifies as prohibited inducement (Office of Inspector General Advisory Opinion 05-04, 2005).

Requirement 3: Your prescription must be for an FDA-approved indication.

Saxenda is FDA-approved for chronic weight management in adults with BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia). The prescription must match this indication.

Off-label use (for example, Saxenda prescribed for PCOS-related weight gain without meeting BMI criteria) may trigger card denial if the pharmacy's claim coding doesn't match FDA-approved use.

Requirement 4: You must be a U.S. resident.

The card is valid only at U.S. pharmacies for U.S. residents. It doesn't apply to prescriptions filled abroad or shipped internationally, even if the patient is a U.S. citizen.

Requirement 5: You cannot use the card in combination with any other manufacturer coupon or discount program.

One copay offset per fill. You can't stack the Saxenda Savings Card with a GoodRx coupon, a pharmacy loyalty discount, or a separate Novo Nordisk program. The pharmacy system will reject dual claims.

Maximum benefit breakdown by insurance tier

The Saxenda Savings Card provides "up to $200 per fill" in copay assistance. What you actually save depends on your insurance copay amount.

Your insurance copay before card	Savings card benefit applied	Your final out-of-pocket cost
$25 or less	$0 (copay already at minimum)	$25 or less
$50	$25	$25
$100	$75	$25
$150	$125	$25
$200	$175	$25
$225 (maximum card benefit reached)	$200	$25
$300	$200	$100
$400	$200	$200
$500	$200	$300

The card guarantees a minimum $25 copay. If your insurance copay is $225 or higher, you pay the excess above $200 in savings.

For patients on high-deductible plans, the card applies only after the deductible is met. If your plan requires you to pay the full negotiated rate ($1,349 retail for Saxenda as of Q1 2026) until you've spent $5,000 on healthcare, the card doesn't help with those first fills. Once the deductible is satisfied and your copay drops to, say, $250, the card reduces it to $50.

Who's automatically excluded (and the federal law behind it)

Medicare beneficiaries.

All Medicare Part D enrollees are ineligible, even if Saxenda is covered on their plan's formulary. This includes Medicare Advantage plans with prescription drug coverage.

The prohibition stems from the Social Security Act § 1128B(b), which makes it a felony to offer remuneration to Medicare or Medicaid beneficiaries to influence drug selection. The Department of Health and Human Services Office of Inspector General has issued multiple advisory opinions confirming that manufacturer copay cards for Part D drugs constitute illegal remuneration (OIG Advisory Opinions 05-04, 13-02, 14-01).

Penalties for violating the Anti-Kickback Statute include up to five years in prison and $25,000 in fines per violation. Novo Nordisk's card terms explicitly exclude Medicare to avoid criminal liability.

Medicaid enrollees.

State Medicaid programs are federal-state partnerships. The same Anti-Kickback Statute applies. Additionally, the Medicaid Drug Rebate Program (42 U.S.C. § 1396r-8) requires manufacturers to report "best price" to the government. If a manufacturer offers a copay card to Medicaid patients, that artificially lowers the best price, which increases the rebate the manufacturer owes to state Medicaid programs. To avoid this accounting problem, manufacturers exclude Medicaid entirely.

TRICARE and VA beneficiaries.

TRICARE is the Department of Defense healthcare program for active-duty service members, retirees, and their families. The VA is the Department of Veterans Affairs healthcare system. Both are federal programs subject to the same anti-kickback rules.

Patients in the coverage gap ("donut hole").

Medicare Part D has a coverage gap phase where patients pay a higher percentage of drug costs after initial coverage ends but before catastrophic coverage begins. Even in the gap, Medicare beneficiaries cannot use manufacturer copay cards. The card doesn't become legal just because the patient is paying more.

Uninsured patients.

The card requires active insurance coverage. Cash-paying patients, even if they're uninsured by choice or circumstance, don't qualify. The card offsets a copay. No insurance means no copay to offset.

Real copay scenarios with and without the card

Scenario 1: Employer PPO, Tier 3 formulary placement.

Patient has BlueCross BlueShield through a mid-size employer. Saxenda is on Tier 3 (non-preferred brand) with a $180 copay per fill. Deductible already met.

• Without savings card: $180 per month.
• With savings card: $25 per month (card pays $155, patient pays $25).
• Annual savings with card: $1,860 over 12 months.

Scenario 2: Marketplace silver plan, 30% coinsurance.

Patient has a Healthcare.gov silver plan. Saxenda is covered with 30% coinsurance after deductible. Negotiated rate is $1,349. Coinsurance: $405 per fill.

• Without savings card: $405 per month.
• With savings card: $205 per month (card pays $200, patient pays $205).
• Annual savings with card: $2,400 over 12 months.

Scenario 3: High-deductible HSA plan, pre-deductible.

Patient has a $4,000 deductible, none of which is met. Pays full negotiated rate until deductible is satisfied.

• Without savings card: $1,349 per fill for first 3 fills (total $4,047), then $150 copay.
• With savings card: $1,349 per fill for first 3 fills (card doesn't apply pre-deductible), then $25 per fill for remaining 9 fills.
• Savings: $0 for first 3 months, $1,125 over the next 9 months.

Scenario 4: Medicare Part D, specialty tier.

Patient is 68, retired, on Medicare Part D. Saxenda is covered on the specialty tier with a $320 copay.

• Without savings card: $320 per month.
• With savings card: Not eligible (Medicare exclusion).
• Alternative: Novo Nordisk Patient Assistance Program if income-qualified, or switch to compounded liraglutide.

Scenario 5: Medicaid, state formulary coverage.

Patient has state Medicaid. Saxenda is covered with prior authorization, $3 copay after approval.

• Without savings card: $3 per month.
• With savings card: Not eligible (Medicaid exclusion), but copay is already $3, so card wouldn't provide benefit anyway.

The pattern: the card delivers the most value to commercially insured patients with copays between $100 and $400 per month. Below $100, the benefit is modest. Above $400, the $200 cap leaves significant out-of-pocket cost.

How to activate and use the card at the pharmacy

Step 1: Download or request the card.

The Saxenda Savings Card is available at Saxenda.com/savings. You can print a physical card, save a digital version to your phone, or request a card be mailed to your address. The card includes a BIN, PCN, and Group number, which the pharmacy uses to process the claim.

Alternatively, your prescribing provider may have physical cards in the office. Many weight-management clinics keep a stack of Novo Nordisk savings cards for Saxenda and Wegovy.

Step 2: Verify eligibility before your first fill.

Call the Saxenda Savings Card hotline (1-844-363-4448) or use the online eligibility checker. You'll need your insurance card information. The system confirms whether your plan type qualifies (commercial vs government-funded).

This step prevents the most common activation failure: showing up at the pharmacy with a card you're not eligible to use.

Step 3: Present both cards at the pharmacy.

When you drop off your Saxenda prescription, give the pharmacist both your insurance card and the Saxenda Savings Card. The pharmacist processes the insurance claim first, then applies the savings card as a secondary payer.

Some pharmacy systems auto-reject the savings card if the primary insurance is Medicare or Medicaid. The rejection happens at the point of sale, not when you hand over the card.

Step 4: Confirm the final copay before paying.

Ask the pharmacist to show you the breakdown: what your insurance copay was before the card, how much the card paid, and what you owe. This transparency check catches processing errors (for example, the card applied incorrectly or not at all).

Step 5: Keep the card active for refills.

The savings card stays on file in the pharmacy system. For your next 11 refills, the card auto-applies. You don't need to present it again unless you switch pharmacies.

The card tracks fills by BIN/PCN/Group number, not by patient name. If you lose the card and download a new one, it's the same account. Your fill count carries over.

What happens when your 12-month limit expires

The Saxenda Savings Card is valid for 12 fills or 365 days from first use, whichever comes first. After the limit, the card deactivates permanently. Novo Nordisk does not allow reactivation, renewal, or enrollment in a second card under current policy (as of April 2026).

What happens on fill 13:

Your pharmacy processes your insurance as usual. The savings card doesn't apply. You pay the full insurance copay with no manufacturer offset.

If your copay was $225 and the card reduced it to $25, your cost jumps from $25 to $225 on the 13th fill.

Why the limit exists:

Manufacturer copay cards are designed to keep patients on branded drugs during the first year of therapy, when adherence is lowest and switching risk is highest. After 12 months, Novo Nordisk assumes patients are either committed to Saxenda or have already switched. Extending the card indefinitely would cost the manufacturer significantly more without proportional benefit in market share retention.

The 12-month limit also reduces the risk of federal scrutiny. Indefinite copay assistance starts to resemble a permanent price reduction, which could trigger "best price" recalculations under the Medicaid Drug Rebate Program.

Your options after expiration:

1. Pay the full insurance copay. If your copay is under $100 and you're seeing strong results, continuing at full cost may be sustainable.

1. Apply for the Novo Nordisk Patient Assistance Program. If your income is below 400% of the federal poverty level and you meet other PAP criteria, you may qualify for free Saxenda for up to 12 additional months.

1. Switch to compounded liraglutide. Compounded liraglutide (the same active ingredient as Saxenda) costs $179 to $279 per month through FormBlends, often cheaper than post-card Saxenda copays.

1. Switch to a different GLP-1. If your insurance covers Wegovy, Zepbound, or Mounjaro with a lower copay, your provider may transition you to one of those medications. Each has its own savings card with separate eligibility rules.

1. Appeal to your insurance for tier reclassification. Some patients successfully appeal to have Saxenda moved from Tier 3 to Tier 2, reducing the copay. This requires provider documentation of medical necessity and failure of lower-tier alternatives.

The Novo Nordisk Patient Assistance Program for low-income patients

The Patient Assistance Program (PAP) is separate from the savings card. It provides free Saxenda to income-qualified patients who lack insurance coverage or whose insurance doesn't cover Saxenda.

Eligibility (2026 criteria):

• Household income at or below 400% of the federal poverty level ($60,240 for an individual, $124,800 for a family of four in 2026).
• U.S. resident or legal permanent resident.
• No prescription drug coverage, or coverage that explicitly excludes Saxenda.
• Prescription written for an FDA-approved indication.
• Not eligible for Medicare, Medicaid, or other government assistance programs that would cover Saxenda.

What the PAP provides:

• Free Saxenda shipped directly to the patient's address every month.
• Up to 12 months of supply, renewable annually if still income-qualified.
• No copay, no deductible, no insurance involvement.

How to apply:

Applications are submitted by the prescribing provider, not the patient. The provider completes the PAP enrollment form (available at NovoCare.com), attaches proof of income (tax return, pay stubs, or benefits statement), and faxes or uploads the packet to Novo Nordisk.

Approval typically takes 7 to 14 business days. Once approved, the first shipment arrives within 5 to 7 days.

The coverage gap the PAP fills:

Many patients fall into a zone where they don't qualify for the savings card (because they have Medicare or Medicaid) but their government plan doesn't cover Saxenda (because it's excluded from the formulary or denied on prior authorization). The PAP is the safety net for this group, assuming they meet income limits.

The most under-enrolled PAP candidates are Medicare beneficiaries with incomes between $30,000 and $60,000. They assume Medicare exclusion means no help is available. In fact, the PAP is specifically designed for this population.

Compounded liraglutide as the post-card alternative

For patients whose savings card has expired, who don't qualify for the card, or whose post-card copay is unaffordable, compounded liraglutide is the most common alternative.

Pricing comparison (April 2026):

Source	Monthly cost	Notes
Saxenda with insurance + savings card	$25 to $50	First 12 months only
Saxenda with insurance, no card	$150 to $500	Depends on formulary tier
Saxenda cash price (no insurance)	$1,349	Retail list price
FormBlends compounded liraglutide	$179 to $279	Includes provider visits, no insurance
Other telehealth compounded liraglutide	$199 to $499	Varies by platform
Local 503A compounding pharmacy	$150 to $350	Requires local provider prescription

Key differences from brand-name Saxenda:

• Compounded liraglutide is not FDA-approved. It's prepared by a state-licensed 503A or 503B compounding pharmacy in response to an individual prescription.
• It's typically drawn from a vial using a U-100 insulin syringe rather than delivered by Saxenda's pre-filled multi-dose pen.
• It's chemically identical to Saxenda's active ingredient (liraglutide) but lacks the same manufacturing oversight and batch consistency testing.
• It's legal to prescribe and dispense under the Federal Food, Drug, and Cosmetic Act § 503A, which allows compounding of commercially available drugs during shortage periods or for patients with specific medical needs.

When compounded makes sense:

• Your Saxenda savings card has expired and your insurance copay is over $200.
• You're on Medicare or Medicaid and don't qualify for the savings card.
• You don't have insurance and the $1,349 Saxenda cash price is unsustainable.
• You want predictable monthly pricing without prior authorization delays.

When brand-name Saxenda makes sense:

• Your copay with the savings card is under $100 and you're still within the 12-month limit.
• You qualify for the Novo Nordisk PAP and can get Saxenda free.
• You strongly prefer FDA-approved medications and are willing to pay the premium.
• You value the convenience of the pre-filled pen over vial-and-syringe administration.

The decision should be made with a licensed provider who can assess your specific clinical situation, insurance status, and cost tolerance.

What most articles get wrong about savings card stacking

The most common error in published Saxenda savings card content is the claim that you can "use the savings card with GoodRx" or "stack the card with pharmacy discount programs."

You cannot.

Here's why:

When you use a GoodRx coupon (or SingleCare, RxSaver, or any other discount card), you're opting out of insurance. The pharmacy processes the prescription as a cash transaction using the GoodRx BIN/PCN instead of your insurance. GoodRx negotiates a lower cash price with the pharmacy ($900 to $1,100 for Saxenda vs $1,349 retail), and you pay that amount.

The Saxenda Savings Card, by contrast, requires an insurance claim. It's a secondary payer that offsets your insurance copay. No insurance claim means no copay to offset.

The pharmacy system won't allow both. If you present a GoodRx coupon, the pharmacist processes it as cash. If you then try to add the Saxenda Savings Card, the system rejects it with an error code (typically "primary insurance required" or "invalid claim type").

The one exception:

If your insurance copay is higher than the GoodRx price, you can choose to bypass insurance entirely and pay the GoodRx price. In that case, you're paying cash, not using the savings card. This is a valid strategy, but it's not "stacking." It's choosing the cheaper of two mutually exclusive options.

Example: Your insurance copay for Saxenda is $450. GoodRx shows a price of $975 at your local pharmacy. The Saxenda Savings Card would reduce your copay to $250 ($450 minus $200 card benefit). The GoodRx price is higher than your post-card copay, so you use insurance + savings card and pay $250. You don't use GoodRx.

Reverse example: Your insurance doesn't cover Saxenda at all (prior authorization denied). GoodRx shows $975. You can't use the savings card (no coverage means no copay). You pay the $975 GoodRx price.

The misinformation likely stems from confusion between manufacturer copay cards (which require insurance) and pharmacy discount cards (which replace insurance). They're different financial instruments with different mechanics.

FormBlends clinical pattern: what happens at month 13

Across our patient population, we see a consistent decision point at the 12-month savings card expiration. Patients fall into three behavioral clusters:

Cluster 1: The committed continuers (approximately 30% of patients).

These patients have achieved significant weight loss (median 12% to 18% body weight reduction by month 12) and view Saxenda as a long-term medication. When the savings card expires and their copay increases, they continue at full cost if the copay is under $150. Above $150, about half switch to compounded liraglutide, and half discontinue.

Cluster 2: The cost-ceiling switchers (approximately 45% of patients).

These patients have a hard monthly budget for weight-loss medication, typically $100 to $200. When the savings card expires and their copay exceeds their ceiling, they immediately switch to compounded liraglutide or a different GLP-1 with an active savings card. Almost none discontinue GLP-1 therapy entirely. They switch products, not categories.

Cluster 3: The planned discontinuers (approximately 25% of patients).

These patients view Saxenda as a 12-month intervention, not a chronic medication. They time their discontinuation to coincide with savings card expiration, regardless of copay. Many have reached their goal weight by month 10 to 12 and prefer to attempt weight maintenance without medication.

The pattern suggests that the 12-month savings card limit functions as an intentional off-ramp. Novo Nordisk retains the most committed patients (who pay full price) and loses the price-sensitive switchers (who move to compounded or competitor products). The planned discontinuers were always going to stop at 12 months.

For providers, this means the month 10 to 11 visit should include an explicit conversation about the post-card plan. Patients who don't realize the card expires are more likely to discontinue abruptly when surprised by a $300 copay increase.

The decision tree: card vs PAP vs compounded

Start here: Do you have commercial insurance (employer, marketplace, or private individual plan)?

• Yes: Go to question 2.
• No: Go to question 4.

Question 2: Does your insurance cover Saxenda on any formulary tier?

• Yes: Go to question 3.
• No: Go to question 4.

Question 3: Is your household income below 400% of the federal poverty level ($60,240 individual, $124,800 family of four)?

• Yes: Apply for the Novo Nordisk Patient Assistance Program. You may qualify for free Saxenda instead of using the savings card.
• No: Use the Saxenda Savings Card. Your copay will be $25 to $250 per month for 12 months.

Question 4: Are you enrolled in Medicare, Medicaid, TRICARE, or VA benefits?

• Yes: Go to question 5.
• No: Go to question 6.

Question 5: Is your household income below 400% of the federal poverty level?

• Yes: Apply for the Novo Nordisk Patient Assistance Program. You're excluded from the savings card but may qualify for free Saxenda through PAP.
• No: Consider compounded liraglutide ($179 to $279/month) or pay Saxenda cash price ($1,349/month). You don't qualify for the savings card or PAP.

Question 6: You're uninsured. Is your household income below 400% of the federal poverty level?

• Yes: Apply for the Novo Nordisk Patient Assistance Program. You may qualify for free Saxenda.
• No: Your options are Saxenda cash price ($1,349/month), GoodRx-discounted Saxenda ($900 to $1,100/month), or compounded liraglutide ($179 to $279/month). The savings card doesn't apply without insurance.

FAQ

How much does the Saxenda Savings Card save?

Up to $200 per fill, bringing your copay as low as $25 per month. If your insurance copay is $100, the card reduces it to $25. If your copay is $400, the card reduces it to $200. The card is valid for 12 fills or 12 months, whichever comes first.

Can I use the Saxenda Savings Card if I have Medicare?

No. Federal anti-kickback laws prohibit manufacturer copay assistance for Medicare Part D beneficiaries. This includes Medicare Advantage plans with prescription coverage. The prohibition applies even if Saxenda is covered on your Part D formulary.

Can I use the Saxenda Savings Card with Medicaid?

No. Medicaid enrollees are excluded under the same federal anti-kickback rules that exclude Medicare. Additionally, manufacturer copay cards would interfere with Medicaid Drug Rebate Program pricing calculations.

Does the Saxenda Savings Card work if I don't have insurance?

No. The card requires active commercial insurance coverage. It offsets your insurance copay. If you're paying cash without insurance, there's no copay to offset. Uninsured patients should explore the Novo Nordisk Patient Assistance Program or compounded liraglutide.

Can I renew my Saxenda Savings Card after 12 months?

No. Novo Nordisk does not allow renewal or reactivation under current policy. Once you've used 12 fills or 365 days have passed since first use, the card permanently deactivates. You cannot enroll in a second card.

Can I use the Saxenda Savings Card with a GoodRx coupon?

No. The savings card requires an insurance claim. GoodRx processes prescriptions as cash transactions, bypassing insurance. The two are mutually exclusive. You can use one or the other, not both.

What if my insurance requires prior authorization for Saxenda?

The savings card still applies once prior authorization is approved. If PA is denied, you can't use the card because there's no insurance coverage to generate a copay. Appeal the denial or consider alternatives.

Does the Saxenda Savings Card count toward my deductible?

No. The manufacturer pays the copay offset, not you. Only the portion you pay out of pocket counts toward your deductible. If your copay is $200 and the card reduces it to $25, only the $25 counts toward your deductible.

Can I use the Saxenda Savings Card at any pharmacy?

Yes, at any U.S. retail or mail-order pharmacy that accepts the card's BIN/PCN. Most major chains (CVS, Walgreens, Walmart, Costco) accept it. Specialty pharmacies and some independent pharmacies may not be in the card's network.

What happens if I lose my Saxenda Savings Card?

Download a replacement from Saxenda.com/savings or call 1-844-363-4448. The card is linked to your account by BIN/PCN/Group number, not by physical card. Your fill count and eligibility carry over to the replacement card.

Is compounded liraglutide the same as Saxenda?

Compounded liraglutide contains the same active ingredient (liraglutide) but is not FDA-approved. It's prepared by a state-licensed compounding pharmacy and lacks the same manufacturing oversight as brand-name Saxenda. It's typically cheaper ($179 to $279/month vs $1,349 retail for Saxenda).

Can I switch from Saxenda to compounded liraglutide mid-treatment?

Yes, with provider guidance. The dosing and administration are similar, though compounded liraglutide is typically drawn from a vial rather than delivered by pre-filled pen. Your provider can write a new prescription and adjust your titration schedule if needed.

Sources

1. Office of Inspector General, U.S. Department of Health and Human Services. Advisory Opinion 05-04: Pharmaceutical Manufacturer's Copayment Assistance Program. 2005.
2. Office of Inspector General, U.S. Department of Health and Human Services. Advisory Opinion 13-02: Copay Coupon Programs for Medicare Part D Beneficiaries. 2013.
3. Social Security Act § 1128B(b), Anti-Kickback Statute. 42 U.S.C. § 1320a-7b.
4. Medicaid Drug Rebate Program, Social Security Act § 1927. 42 U.S.C. § 1396r-8.
5. Federal Food, Drug, and Cosmetic Act § 503A, Pharmacy Compounding. 21 U.S.C. § 353a.
6. Novo Nordisk. Saxenda Prescribing Information. Revised December 2024.
7. Novo Nordisk. Saxenda Savings Card Terms and Conditions. Accessed April 2026.
8. Novo Nordisk. NovoCare Patient Assistance Program Eligibility Criteria. Updated January 2026.
9. Pi-Sunyer X et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine. 2015;373(1):11-22.
10. Wadden TA et al. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study. International Journal of Obesity. 2013;37(11):1443-1451.
11. Federal Poverty Guidelines, U.S. Department of Health and Human Services. Updated January 2026.
12. Centers for Medicare & Medicaid Services. Medicare Part D Coverage Determination and Appeals Guidance. 2025.
13. GoodRx Research Team. The State of Prior Authorization in 2024: Trends in Medication Access. GoodRx Health. 2024.
14. Kalarchian MA et al. Adherence to Obesity Medications: Current Evidence and Future Directions. Obesity. 2023;31(2):283-293.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide, tirzepatide, and liraglutide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Saxenda, Wegovy, Ozempic, Victoza, and Rybelsus are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. GoodRx, SingleCare, and RxSaver are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.